Investigational Drug Information for LY3214996
✉ Email this page to a colleague
What is the development status for investigational drug LY3214996?
LY3214996 is an investigational drug.
There have been 10 clinical trials for LY3214996.
The most recent clinical trial was a Phase 1 trial, which was initiated on May 27th 2020.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, and Adenocarcinoma. The leading clinical trial sponsors are Eli Lilly and Company, Dana-Farber Cancer Institute, and Ivy Brain Tumor Center.
There are two US patents protecting this investigational drug and forty-two international patents.
Summary for LY3214996
| US Patents | 2 |
| International Patents | 42 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 1 (2020-05-27) |
| Vendors | 41 |
Recent Clinical Trials for LY3214996
| Title | Sponsor | Phase |
|---|---|---|
| Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers | Lustgarten Foundation | Phase 1 |
| Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers | The Netherlands Cancer Institute | Phase 1 |
| Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) | Loxo Oncology, Inc. | Phase 1 |
Clinical Trial Summary for LY3214996
Top disease conditions for LY3214996
Top clinical trial sponsors for LY3214996
US Patents for LY3214996
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| LY3214996 | ⤷ Try a Trial | ERK inhibitors | Eli Lilly and Company (Indianapolis, IN) | ⤷ Try a Trial |
| LY3214996 | ⤷ Try a Trial | ERK inhibitors | Eli Lilly and Company (Indianapolis, IN) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for LY3214996
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| LY3214996 | Argentina | AR102977 | 2034-12-22 | ⤷ Try a Trial |
| LY3214996 | Australia | AU2015369983 | 2034-12-22 | ⤷ Try a Trial |
| LY3214996 | Brazil | BR112017011130 | 2034-12-22 | ⤷ Try a Trial |
| LY3214996 | Canada | CA2966559 | 2034-12-22 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
